Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Dronedarone

Menu
$ API Ref.Price (USD/KG) : 502Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5SANOFI AVENTIS US

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-04-16

DRONEDARONE HYDROCHLORIDE

US Patent Number : 8410167

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1387

Delist Requested :

Patent Use Description : REDUCTION IN RISK OF H...

Patent Expiration Date : 2029-04-16

Sanofi Company Banner

02

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-04-16

DRONEDARONE HYDROCHLORIDE

US Patent Number : 9107900

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1728

Delist Requested :

Patent Use Description : REDUCTION IN RISK OF H...

Patent Expiration Date : 2029-04-16

Sanofi Company Banner

03

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-04-16

DRONEDARONE HYDROCHLORIDE

US Patent Number : 9107900

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1726

Delist Requested :

Patent Use Description : REDUCTION IN RISK OF H...

Patent Expiration Date : 2029-04-16

Sanofi Company Banner

04

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-04-16

DRONEDARONE HYDROCHLORIDE

US Patent Number : 8410167

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1388

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2029-04-16

Sanofi Company Banner

05

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2031-06-30

DRONEDARONE HYDROCHLORIDE

US Patent Number : 8602215

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1473

Delist Requested :

Patent Use Description : MANAGEMENT OF RISK OF ...

Patent Expiration Date : 2031-06-30

Sanofi Company Banner